FDA issues new antidepressant warnings

The U.S. Food and Drug Administration proposed that the labels of all antidepressant medications warn of increased risks of suicidal thoughts and behavior for young adults, ages 18 to 24.

Here is the complete list:

Desyrel (trazodone HCl)

Elavil (amitriptyline)

Effexor (venlafaxine HCl)

Emsam (selegiline)

Etrafon (perphenazine/amitriptyline)

fluvoxamine maleate

Lexapro (escitalopram hydrobromide)

Limbitrol (chlordiazepoxide/amitriptyline)

Ludiomil (maprotiline)

Marplan (isocarboxazid)

Nardil (phenelzine sulfate)

nefazodone HCl

Norpramin (desipramine HCl)

Pamelor (nortriptyline)

Parnate (tranylcypromine sulfate)

Paxil (paroxetine HCl)

Pexeva (paroxetine mesylate)

Prozac (fluoxetine HCl)

Remeron (mirtazapine)

Sarafem (fluoxetine HCl)

Seroquel (quetiapine)

Sinequan (doxepin)

Surmontil (trimipramine)

Symbyax (olanzapine/fluoxetine)

Tofranil (imipramine)

Tofranil-PM (imipramine pamoate)

Triavil (perphenazine/amitriptyline)

Vivactil (protriptyline)

Wellbutrin (bupropion HCl)

Zoloft (sertraline HCl)

Zyban (bupropion HCl)

Source: Food and Drug Administration

MORE FROM MENTAL HEALTH

Mental health Section Front

Study: Clozapine may have saved schizophrenics Deadliest day for suicides: Wednesday Family history key to severity of depression Jackson kids face hurdles coping with his death Schizophrenia risk tied to gene variants Teens who move a lot have twice suicide risk ‘Phantom fat’ can linger after weight loss Blogger apologizes for her hoax about sick fetus FDA to parents: Don't toss ADHD drugs yet FDA panel OKs 3 psychiatric drugs for kids Mental health Section Front   Add Mental health headlines to your news reader: